Skip to main content
1 April 2025
Last updated:
Sunday 30 March 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Swiss companies weather the turmoil in 2022
Read more
Capturing the promise of p38 MAPK inhibition
Read more
Destiny Pharma advances strategy against bacteria
Read more
Adrenomed prepares global study in septic shock
Read more
Microbiome-based therapies as anti-cancer agents
Read more
Antibody-drug conjugates come to the fore
Read more
Antimicrobial Review: New research, new payment models
Read more
Cancer Research UK has new model
Read more
How European MidPharmas have grown profits
Read more
Meeting the need for better reproductive health
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
››
Last page
Last »
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
